NCT04658368 is a clinical trial of Primary TMR in Amputation, sponsored by University of Wisconsin, Madison.

Who is sponsoring NCT04658368?

NCT04658368 is sponsored by University of Wisconsin, Madison.

What drugs are being tested in NCT04658368?

Interventions in NCT04658368: Primary TMR, Secondary TMR.

What condition does NCT04658368 study?

NCT04658368 studies Amputation.

Is NCT04658368 still recruiting?

NCT04658368 is currently terminated. Last updated 5 November 2025.

Last reviewed 2025-11-05 · How we verify

NCT04658368

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Patient Reported Outcomes Following Targeted Muscle Reinnervation

Terminated Last updated 5 November 2025

What this trial tests

trial testing Primary TMR in Amputation in 2 participants. Terminated before completion.

Timeline

29 December 2020

Primary endpoint
1 September 2022

1 September 2022

Quick facts

Lead sponsor	University of Wisconsin, Madison
Status	Terminated
Study type	OBSERVATIONAL
Enrollment	2
Start date	29 December 2020
Primary completion	1 September 2022
Estimated completion	1 September 2022
Sites	1 location across United States

Drugs / interventions tested

Primary TMR
Secondary TMR

Conditions studied

Amputation — all drugs for Amputation →

Sponsor

University of Wisconsin, Madison

Who can join

18 and older, any sex, with Amputation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to characterize the functional status and quality of life of patients undergoing Targeted Muscle Reinnervation (TMR) at time of major limb amputation (primary) or subsequent to major limb amputation (secondary). Participants can expect to be on study for about a year and will complete a short electronic survey and option phone interview.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Amputation

Currently open trials in the same condition.

NCT07401966 — Amputations in Childhood and Neuropathic Pain · recruiting
NCT07265154 — Gait Training and Artificial Intelligence · NA · recruiting
NCT07263945 — Influence of Prosthetic Foot Stiffness on Transtibial Osseointegrated Bone-Anchored Limb Outcomes · Phase 1 · recruiting
NCT07347561 — A Comparison of Myoelectric and Bionic Hands · recruiting
NCT07364266 — Analgesic Amputation for Algodystrophy: Feedback From a Case Series · active not recruiting

Other University of Wisconsin, Madison trials

Trials by the same sponsor.

NCT07440004 — Testing a Digital Mindfulness Program to Support People Experiencing Suicidal Thoughts · Phase 1 · recruiting
NCT07278466 — The COMParing App Support Strategies Study · NA · recruiting
NCT07475104 — Redesigning Surgical Care for Patients in Wisconsin · NA · enrolling by invitation
NCT07470723 — The ORIGIN-FH Study · NA · recruiting
NCT06975657 — Well-being Skills for Reentry · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04658368 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Wisconsin, Madison
Last refreshed: 5 November 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04658368.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing